Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$28.00 Web:$25.20 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Immunization Safety Review: Vaccines and Autism Immunization Safety Review: Influenza Vaccines and Neurological Complications Other Related Titles Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer (2002) Board on Health Promotion and Disease Prevention (HPDP) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 96   E-mail  Facebook  Digg  Stumble  Twitter More Page 96 Front Matter (R1-R16) Executive Summary (1-18) Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer (19-84) Appendix A: Committee Recommendations and Conclusions from Previous Reports (85-95) Appendix B: Agenda (96-97) Appendix C: Chronology of Important Events Regarding Vaccine Safety (98-102)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 96
Appendix B Public Meeting Agenda July 1 1' 2002 Immunization Safety Review Committee SV40 Contamination of Polio Vaccine and Cancer National Academy of Sciences Main Building Lecture Hall, 2100 C St, NW Washington DC 8:45-9:00 am Welcome and Opening Remarks Marie McCormick, MD, ScD Committee Chair 9:00-9:15 am Brief History and Important Questions William Egan, PhD, CBER, FDA 9:15-11:15 am Epidemiological Evidence Regarding Causality Between SV40-contaminated Polio Vaccines and Human Cancers Howard Striclder, MO, MPH Albert Einstein College of Medicine Susan Fisher, MD, University of Rochester Eric Engels' MD, ASH, NCI, NIH 11:15-11:30 am Break 96

OCR for page 97
APPENDIX B 97 11:30-12:45 pm SV40 Detection and Transmission Keerti Shah, MD, DrPH Johns Hopkins Bloomberg School of Public Health Jeffrey Kopp, MD, NIDDK, NIH 12:45-1:45 pm Lunch 1:45-4:15 pm The Presence and Mechanisms of SV40 in Human Cancers Janet Butel, PhD Baylor University School of Medicine Michele Carbone, MD, PhD Loyola University School of Medicine 4:15pm 5:30 pm Discussion and Public Comment Adjourn

Representative terms from entire chapter:

evidence regarding